Russell Investments Group
MDGL icon

Russell Investments Group’s Madrigal Pharmaceuticals MDGL Stock Holding History

Russell Investments Group’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.5M Buy
49,294
+4,790
+11% +$2.45M 0.02% 624
2026
Q1 		$23.3M Sell
44,504
-3,655
-8% -$1.75M 0.03% 590
2025
Q4 		$28M Buy
48,159
+3,274
+7% +$1.67M 0.03% 511
2025
Q3 		$20.6M Buy
44,885
+10,870
+32% +$4.06M 0.02% 610
2025
Q2 		$10.3M Buy
34,015
+4,441
+15% +$1.32M 0.01% 840
2025
Q1 		$9.8M Buy
29,574
+28,092
+1,896% +$9.23M 0.01% 835
2024
Q4 		$457K Buy
1,482
+809
+120% +$228K ﹤0.01% 2297
2024
Q3 		$143K Sell
673
-8,629
-93% -$2.21M ﹤0.01% 2580
2024
Q2 		$2.61M Buy
9,302
+3,814
+69% +$908K ﹤0.01% 1504
2024
Q1 		$1.47M Buy
+5,488
New +$1.29M ﹤0.01% 1814
2023
Q4 		– Sell
-5
Closed -$730 – 3269
2023
Q3 		$730 Sell
5
-120
-96% -$22.6K ﹤0.01% 3368
2023
Q2 		$28.9K Sell
125
-100
-44% -$27.1K ﹤0.01% 2788
2023
Q1 		$54.5K Buy
+225
New +$61.3K ﹤0.01% 2702
2019
Q3 		– Sell
-15,313
Closed -$1.6M – 3065
2019
Q2 		$1.6M Buy
15,313
+10,868
+244% +$1.16M ﹤0.01% 1777
2019
Q1 		$557K Buy
+4,445
New +$553K ﹤0.01% 2306

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Russell Investments Group's MDGL Position: Q2 2026 in Review

Russell Investments Group increased its Madrigal Pharmaceuticals (MDGL) stake by 11% in Q2 2026, buying an estimated $2.45M and bringing the position to 49,294 shares worth $26.5M. The position accounts for 0.02% of the portfolio, ranked #624.

Russell Investments Group first reported a position in MDGL in Q1 2019 and has held it in 15 quarters since. The position peaked at $28M in Q4 2025. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Russell Investments Group held 49,294 shares of Madrigal Pharmaceuticals worth $26.5M as of Q2 2026.
  • Russell Investments Group bought 4,790 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $2.45M.
  • Madrigal Pharmaceuticals made up 0.02% of Russell Investments Group's portfolio in Q2 2026, its #624 holding.
  • Russell Investments Group first reported a position in Madrigal Pharmaceuticals in Q1 2019 and has held it in 15 quarters since.
  • Russell Investments Group's Madrigal Pharmaceuticals position peaked at $28M in Q4 2025.
  • 414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.